Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21347593 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions
Conditions: Coronary Artery Disease;   Coronary Disease;   Coronary Stenosis
Intervention: Device: Hybrid sirolimus- and everolimus-eluting stents (ORSIRO, XIENCE PRIME)

Study has passed its completion date and status has not been verified in more than two years.